Table 2 Distribution of pediatric residents by responses to the SPARUM* questions (n:187)
SPARUM* Questions | Never-Seldom | Sometimes | Frequently-Always |
|---|---|---|---|
Physician-Patient Relationship Dimension | |||
Explaining the disease and its causes | 2 (1.0) | 14 (7.5) | 171 (91.5) |
Explaining the rationale for treatment | 2 (1.0) | 11 (5.9) | 168 (93.1) |
Patients’ understanding of the information provided | 14 (7.5) | 74 (39.6) | 99 (52.9) |
Do not repeat the information given | 52 (27.8) | 71 (38.0) | 64 (34.2) |
Providing information about the medicines prescribed | 1 (0.5) | 12 (6.4) | 174 (93.1) |
Prescribing medicines requested by patients | 82 (43.9) | 93 (49.7) | 12 (6.4) |
Information on storage conditions of medicines | 64 (34.2) | 59 (31.6) | 64 (34.2) |
Informing patients and the public about RUM | 46 (24.6) | 68 (36.4) | 73 (39.0) |
Physician-Treatment Regulation Relationship Dimension | |||
Considering the feasibility of treatment | (-) | 19 (10.2) | 168 (89.8) |
Cost consideration | 34 (18.1) | 66 (35.3) | 87 (46.6) |
Prescribing more than the required number of medicines | 154 (82.3) | 28 (15.0) | 5 (2.7) |
Recommendingn on-medicine treatment | 6 (3.2) | 21 (11.2) | 160 (85.6) |
Prescribing the same medication to the patient with the same complaint in the use of one box of two boxes of prescribed medication | 101 (54.0) | 65 (34.8) | 21 (11.2) |
Re-prescribing a medicine prescribed by another physician without examining him/her | 175 (93.6) | 9 (4.8) | 3 (1.6) |
Evaluation of treatment outcome | 32 (17.1) | 79 (42.2) | 76 (40.7) |
Monitoring the patient’s condition | 44 (23.5) | 77 (41.2) | 66 (35.3) |
Physician-Medication Knowledge Relationship Dimension | |||
Prescribing without examination | 175 (93.6) | 6 (3.2) | 6 (3.2) |
Knowing the prices of prescribed medicines | 73 (39.0) | 70 (37.4) | 44 (23.6) |
Impact of the presence of social security on medicine selection | 47 (25.1) | 63 (33.7) | 77 (41.2) |
Being influenced by the presentation of medicine promotion staff | 96 (51.3) | 77 (41.2) | 14 (7.5) |
Influence of other physicians on medicine promotion staff presentations | 34 (18.2) | 110 (58.8) | 43 (23.0) |
Consulting colleagues when in doubt | 3 (1.6) | 49 (26.2) | 135 (72.2) |
Following policies and legislation related to pharmaceuticals | 90 (48.2) | 67 (35.8) | 30 (16.0) |